Sign in

CIK 0001357459 · Non-accelerated filer<br>Smaller reporting company

PALISADE BIO, INC.

Sign in to watch
Ticker
PALI
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
522007292
Phone
(858) 704-4900
Business address
7750 EL CAMINO REAL, SUITE 5200, CARLSBAD, CA, 92009
Former names
PALISADE BIO, INC., Seneca Biopharma, Inc., Neuralstem, Inc.
  1. 4 Derivatives Options or other derivatives
  2. 4 Option exercise Director acquired 388 shares (option exercise)
  3. 4 Option exercise Director acquired 388 shares (option exercise)
  4. 4 Derivatives Options or other derivatives
  5. 4 Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 4 Option exercise Director acquired 465 shares (option exercise)
  8. 4 Option exercise Director acquired 340 shares (option exercise)
  9. 4 Shares withheld for taxes Chief Medical Officer gave up 1,271 shares (to pay taxes)
  10. 4 Shares withheld for taxes CEO, CFO, Director gave up 2,033 shares (to pay taxes)
  11. 4 Open-market buy Director bought 1,000 shares at $4.86 ($4,863)
  12. 4 Open-market buy CEO, CFO, Director bought 1,000 shares at $4.81 ($4,810)
  13. 4 Grant or award CEO, CFO, Director acquired 666 shares (grant or award)
  14. 3 Insider Initial Statement of Ownership
  15. 4 Shares withheld for taxes CEO, CFO, Director gave up 137 shares (to pay taxes)
  16. 4 Shares withheld for taxes CEO, CFO, Director gave up 128 shares (to pay taxes)
  17. 4 Option exercise CEO, CFO, Director acquired 5,558 shares (option exercise)
  18. 4 Option exercise Director acquired 10,920 shares (option exercise)
  19. 4 Option exercise Director acquired 12,800 shares (option exercise)
  20. 4 Option exercise Director acquired 10,920 shares (option exercise)

Page 3 of 18 · 343 filings